Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-24

Clinical Trial Update: Comparison of Sacubitril/Valsartan Versus Enalapril on Effect on NT-proBNP in Patients Stabilized From an Acute Heart Failure Episode. [Phase 4]

View source ↗

Summary

Phase 4 trial comparing sacubitril/valsartan to enalapril on NT-proBNP in patients stabilized after an acute heart failure episode has completed with posted res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Enalapril (enalapril)
  • Sacubitril/Valsartan (sacubitril/valsartan)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Acute Heart Failure | Phase 4 | Status: COMPLETED | Results posted: 2019-09-24